首页> 外文期刊>Клиничесκая лабораторная диагностиκа >TUMOR ASSOCIATED PROTEASES - PROGNOSTIC MARKERS OF COLORECTAL CANCER
【24h】

TUMOR ASSOCIATED PROTEASES - PROGNOSTIC MARKERS OF COLORECTAL CANCER

机译:肿瘤相关蛋白酶-大肠癌的预后标志

获取原文
获取原文并翻译 | 示例
           

摘要

Associations between matrix metalloproteinase (MMP) 2, 7, 9, tissue MMP inhibitor TIMP-1 and plasminogen activation system components (uPA, tPA and PAI-1) plasma and/or tumor levels in colorectal cancer (CRC) patients -were evaluated in order to reveal their potential clinical implications. Two groups of CRC patients monitored for 5 or 10 years were enclosed in the study. Earlier, corresponding markers 'levels were measured in their plasma and/or tumors by immunoenzymatic techniques. High tumor PAI-1 (>4,0 ng/mg protein) was demonstrated to be a significant, but not independent unfavorable prognostic factor for 5 and 10 years overall survival. Its role was mostly pronounced in stage III patients. High preoperative plasma MMP-7 and TIMP-1 levels (cut-offs - 4,0 and 347 ng/ml respectively) were shown to be independent unfavorable prognostic factors, and univariate analysis revealed unfavorable prognostic value of high tumor MMP-7 content (> 7,8 ng/mg protein) in patients with disseminated process.
机译:在大肠癌(CRC)患者中评估了基质金属蛋白酶(MMP)2、7、9,组织MMP抑制剂TIMP-1与纤溶酶原激活系统成分(uPA,tPA和PAI-1)血浆和/或肿瘤水平之间的关联以揭示其潜在的临床意义。本研究包括两组监测5或10年的CRC患者。早期,通过免疫酶技术测量了血浆和/或肿瘤中相应的标志物水平。高肿瘤PAI-1(> 4.0 ng / mg蛋白)被证明是5年和10年总生存期的重要但非独立的不利预后因素。其作用在III期患者中最明显。术前血浆MMP-7和TIMP-1的高水平(分别为4,0和347 ng / ml的临界值)是独立的不良预后因素,单因素分析显示高肿瘤MMP-7含量的不良预后价值( > 7.8 ng / mg蛋白的患者)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号